112 related articles for article (PubMed ID: 7930471)
1. Inhibition of bacterial translocation in obstructive jaundice by muramyl tripeptide phosphatidylethanolamine in the rat.
Ding JW; Andersson R; Soltesz VL; Pärsson H; Johansson K; Wang W; Bengmark S
J Hepatol; 1994 Jun; 20(6):720-8. PubMed ID: 7930471
[TBL] [Abstract][Full Text] [Related]
2. Modification of reticuloendothelial function by muramyl dipeptide-encapsulated liposomes in jaundiced rats treated with biliary decompression.
Ding JW; Andersson R; Hultberg B; Soltesz V; Bengmark S
Scand J Gastroenterol; 1993 Jan; 28(1):53-62. PubMed ID: 8430273
[TBL] [Abstract][Full Text] [Related]
3. The effect of biliary decompression on bacterial translocation in jaundiced rats.
Ding JW; Andersson R; Soltesz V; Willén R; Loft S; Poulsen HE; Pärsson H; Olsson K; Bengmark S
HPB Surg; 1993; 7(2):99-110. PubMed ID: 8268113
[TBL] [Abstract][Full Text] [Related]
4. Maintenance of intestinal epithelium structural integrity and mucosal leukocytes during chemotherapy by oral administration of muramyl tripeptide phosphatidylethanolamine.
Killion JJ; Bucana CD; Radinsky R; Dong Z; O'Reilly T; Bilbe G; Tarcsay L; Fidler IJ
Cancer Biother Radiopharm; 1996 Dec; 11(6):363-71. PubMed ID: 10851497
[TBL] [Abstract][Full Text] [Related]
5. Obstructive jaundice impairs reticuloendothelial function and promotes bacterial translocation in the rat.
Ding JW; Andersson R; Soltesz V; Willén R; Bengmark S
J Surg Res; 1994 Aug; 57(2):238-45. PubMed ID: 8028331
[TBL] [Abstract][Full Text] [Related]
6. The role of bile and bile acids in bacterial translocation in obstructive jaundice in rats.
Ding JW; Andersson R; Soltesz V; Willén R; Bengmark S
Eur Surg Res; 1993; 25(1):11-9. PubMed ID: 8482301
[TBL] [Abstract][Full Text] [Related]
7. Regional muramyl tripeptide phosphatidylethanolamine administration enhances hepatic immune function and tumor surveillance.
Karpoff HM; Jarnagin W; Delman K; Fong Y
Surgery; 2000 Aug; 128(2):213-8. PubMed ID: 10922994
[TBL] [Abstract][Full Text] [Related]
8. Muramyl dipeptide improves mononuclear phagocyte system function in obstructive jaundice.
Dunn CW; Horton JW
J Surg Res; 1990 Mar; 48(3):249-53. PubMed ID: 2314099
[TBL] [Abstract][Full Text] [Related]
9. Gut barrier failure in experimental obstructive jaundice.
Reynolds JV; Murchan P; Leonard N; Clarke P; Keane FB; Tanner WA
J Surg Res; 1996 Apr; 62(1):11-6. PubMed ID: 8606497
[TBL] [Abstract][Full Text] [Related]
10. Obstructive jaundice alters Kupffer cell function independent of bacterial translocation.
Sheen-Chen SM; Chau P; Harris HW
J Surg Res; 1998 Dec; 80(2):205-9. PubMed ID: 9878315
[TBL] [Abstract][Full Text] [Related]
11. Effects of obstructive jaundice and external biliary diversion on bacterial translocation in rats.
Cakmakci M; Tirnaksiz B; Hayran M; Belek S; Gürbüz T; Sayek I
Eur J Surg; 1996 Jul; 162(7):567-71. PubMed ID: 8874165
[TBL] [Abstract][Full Text] [Related]
12. Bacterial translocation from the biliary tract to blood and lymph in rats with obstructive jaundice.
Karsten TM; van Gulik TM; Spanjaard L; Bosma A; van der Bergh Weerman MA; Dingemans KP; Dankert J; Gouma DJ
J Surg Res; 1998 Feb; 74(2):125-30. PubMed ID: 9587350
[TBL] [Abstract][Full Text] [Related]
13. Impaired Kupffer cell function and effect of immunotherapy in obstructive jaundice.
Tomioka M; Iinuma H; Okinaga K
J Surg Res; 2000 Aug; 92(2):276-82. PubMed ID: 10896834
[TBL] [Abstract][Full Text] [Related]
14. Activation of rat Kupffer cells to tumoricidal cells by the immunomodulator muramyl tripeptide-phosphatidylethanolamine incorporated into the novel drug carrier lactosylated low density lipoprotein.
van de Water B; van Berkel TJ; Kuiper J
Mol Pharmacol; 1994 May; 45(5):971-7. PubMed ID: 8190111
[TBL] [Abstract][Full Text] [Related]
15. Reticuloendothelial system phagocytic function in obstructive jaundice and its modification by a muramyl dipeptide analogue.
Pain JA; Collier DS; Ritson A
Eur Surg Res; 1987; 19(1):16-22. PubMed ID: 3792414
[TBL] [Abstract][Full Text] [Related]
16. Role of the gut in the pathophysiology of extrahepatic biliary obstruction.
Clements WD; Parks R; Erwin P; Halliday MI; Barr J; Rowlands BJ
Gut; 1996 Oct; 39(4):587-93. PubMed ID: 8944570
[TBL] [Abstract][Full Text] [Related]
17. Impairment of lymphocyte locomotion in the tumor microenvironment and the effect of systemic immunotherapy with liposome-encapsulated muramyl-tripeptide-phosphatidylethanolamine.
Risin D; Kleinerman ES; Umezu Y; Pizzini RP; Balch CM; Pellis NR
Cancer Immunol Immunother; 1995 Jan; 40(1):57-64. PubMed ID: 7828168
[TBL] [Abstract][Full Text] [Related]
18. Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide (MTPPE) and interferon-y (IFN-y) in experimental infection with Listeria monocytogenes.
Melissen PM; van Vianen W; Bidjai O; van Marion M; Bakker-Woudenberg IA
Biotherapy; 1993; 6(2):113-24. PubMed ID: 8398570
[TBL] [Abstract][Full Text] [Related]
19. The influence of biliary obstruction and sepsis on reticuloendothelial function in rats.
Ding JW; Andersson R; Norgren L; Stenram U; Bengmark S
Eur J Surg; 1992 Mar; 158(3):157-64. PubMed ID: 1356455
[TBL] [Abstract][Full Text] [Related]
20. Changes in gastrointestinal morphology associated with obstructive jaundice.
Parks RW; Stuart Cameron CH; Gannon CD; Pope C; Diamond T; Rowlands BJ
J Pathol; 2000 Dec; 192(4):526-32. PubMed ID: 11113871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
